Tukey's HSD is advantageous in cancer research because it controls the familywise error rate, reducing the risk of Type I errors (false positives). It provides a robust method for dealing with multiple comparisons, which is crucial in studies with numerous treatment arms. Additionally, it is relatively straightforward to implement with standard statistical software, making it accessible to researchers.
